世界の非動物性組換えタンパク質市場予測 2023年-2029年

【英語タイトル】Global Animal-Free Recombinant Proteins Market Growth 2023-2029

LP Informationが出版した調査資料(LP23MY4058)・商品コード:LP23MY4058
・発行会社(調査会社):LP Information
・発行日:2023年5月
・ページ数:71
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非動物性組換えタンパク質市場」は、過去の販売実績から2022年の世界の非動物性組換えタンパク質の総販売量を検討し、2023年から2029年の予測される非動物性組換えタンパク質の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非動物性組換えタンパク質の市場規模を掲載し、XXX百万米ドル規模の世界の非動物性組換えタンパク質市場の詳細な分析を提供します。本インサイトレポートは、世界の非動物性組換えタンパク質業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非動物性組換えタンパク質市場における各社の独自のポジションをより深く理解するために、非動物性組換えタンパク質製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非動物性組換えタンパク質市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非動物性組換えタンパク質の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。非動物性組換えタンパク質の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非動物性組換えタンパク質のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非動物性組換えタンパク質の世界主要メーカーとしては、BioVision、 Bio-Techne、 Abcam、 Merckなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非動物性組換えタンパク質市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非動物性組換えタンパク質市場をセグメンテーションし、種類別 (前臨床用タンパク質、GMP用タンパク質)、用途別 (細胞治療薬製造、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:前臨床用タンパク質、GMP用タンパク質

・用途別区分:細胞治療薬製造、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の非動物性組換えタンパク質市場の10年間の市場状況・展望は?
・世界および地域別に見た非動物性組換えタンパク質市場成長の要因は何か?
・非動物性組換えタンパク質の市場機会はエンドマーケットの規模によってどのように変化するのか?
・非動物性組換えタンパク質のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:非動物性組換えタンパク質の年間販売量2018-2029、地域別現状・将来分析
・非動物性組換えタンパク質の種類別セグメント:前臨床用タンパク質、GMP用タンパク質
・非動物性組換えタンパク質の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・非動物性組換えタンパク質の用途別セグメント:細胞治療薬製造、その他
・非動物性組換えタンパク質の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非動物性組換えタンパク質市場
・企業別のグローバル非動物性組換えタンパク質市場データ:2018-2023年の年間販売量、市場シェア
・企業別の非動物性組換えタンパク質の年間売上:2018-2023年の売上、市場シェア
・企業別の非動物性組換えタンパク質販売価格
・主要企業の非動物性組換えタンパク質生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非動物性組換えタンパク質の地域別レビュー
・地域別の非動物性組換えタンパク質市場規模2018-2023:年間販売量、売上
・主要国別の非動物性組換えタンパク質市場規模2018-2023:年間販売量、売上
・南北アメリカの非動物性組換えタンパク質販売の成長
・アジア太平洋の非動物性組換えタンパク質販売の成長
・ヨーロッパの非動物性組換えタンパク質販売の成長
・中東・アフリカの非動物性組換えタンパク質販売の成長

南北アメリカ市場
・南北アメリカの国別の非動物性組換えタンパク質販売量、売上(2018-2023)
・南北アメリカの非動物性組換えタンパク質の種類別販売量
・南北アメリカの非動物性組換えタンパク質の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非動物性組換えタンパク質販売量、売上(2018-2023)
・アジア太平洋の非動物性組換えタンパク質の種類別販売量
・アジア太平洋の非動物性組換えタンパク質の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非動物性組換えタンパク質販売量、売上(2018-2023)
・ヨーロッパの非動物性組換えタンパク質の種類別販売量
・ヨーロッパの非動物性組換えタンパク質の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非動物性組換えタンパク質販売量、売上(2018-2023)
・中東・アフリカの非動物性組換えタンパク質の種類別販売量
・中東・アフリカの非動物性組換えタンパク質の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非動物性組換えタンパク質の製造コスト構造分析
・非動物性組換えタンパク質の製造プロセス分析
・非動物性組換えタンパク質の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・非動物性組換えタンパク質の主要なグローバル販売業者
・非動物性組換えタンパク質の主要なグローバル顧客

地域別の非動物性組換えタンパク質市場予測レビュー
・地域別の非動物性組換えタンパク質市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非動物性組換えタンパク質の種類別市場規模予測
・非動物性組換えタンパク質の用途別市場規模予測

主要企業分析
BioVision、 Bio-Techne、 Abcam、 Merck
・企業情報
・非動物性組換えタンパク質製品
・非動物性組換えタンパク質販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Animal-Free Recombinant Proteins Industry Forecast” looks at past sales and reviews total world Animal-Free Recombinant Proteins sales in 2022, providing a comprehensive analysis by region and market sector of projected Animal-Free Recombinant Proteins sales for 2023 through 2029. With Animal-Free Recombinant Proteins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-Free Recombinant Proteins industry.
This Insight Report provides a comprehensive analysis of the global Animal-Free Recombinant Proteins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-Free Recombinant Proteins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal-Free Recombinant Proteins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-Free Recombinant Proteins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-Free Recombinant Proteins.
The global Animal-Free Recombinant Proteins market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Animal-Free Recombinant Proteins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Animal-Free Recombinant Proteins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Animal-Free Recombinant Proteins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Animal-Free Recombinant Proteins players cover BioVision, Bio-Techne, Abcam and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal-Free Recombinant Proteins market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Preclinical Proteins
GMP Proteins
Segmentation by application
Cell Therapy Manufacturing
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioVision
Bio-Techne
Abcam
Merck
Key Questions Addressed in this Report
What is the 10-year outlook for the global Animal-Free Recombinant Proteins market?
What factors are driving Animal-Free Recombinant Proteins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal-Free Recombinant Proteins market opportunities vary by end market size?
How does Animal-Free Recombinant Proteins break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Animal-Free Recombinant Proteins Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Animal-Free Recombinant Proteins by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Animal-Free Recombinant Proteins by Country/Region, 2018, 2022 & 2029
2.2 Animal-Free Recombinant Proteins Segment by Type
2.2.1 Preclinical Proteins
2.2.2 GMP Proteins
2.3 Animal-Free Recombinant Proteins Sales by Type
2.3.1 Global Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
2.3.2 Global Animal-Free Recombinant Proteins Revenue and Market Share by Type (2018-2023)
2.3.3 Global Animal-Free Recombinant Proteins Sale Price by Type (2018-2023)
2.4 Animal-Free Recombinant Proteins Segment by Application
2.4.1 Cell Therapy Manufacturing
2.4.2 Other
2.5 Animal-Free Recombinant Proteins Sales by Application
2.5.1 Global Animal-Free Recombinant Proteins Sale Market Share by Application (2018-2023)
2.5.2 Global Animal-Free Recombinant Proteins Revenue and Market Share by Application (2018-2023)
2.5.3 Global Animal-Free Recombinant Proteins Sale Price by Application (2018-2023)
3 Global Animal-Free Recombinant Proteins by Company
3.1 Global Animal-Free Recombinant Proteins Breakdown Data by Company
3.1.1 Global Animal-Free Recombinant Proteins Annual Sales by Company (2018-2023)
3.1.2 Global Animal-Free Recombinant Proteins Sales Market Share by Company (2018-2023)
3.2 Global Animal-Free Recombinant Proteins Annual Revenue by Company (2018-2023)
3.2.1 Global Animal-Free Recombinant Proteins Revenue by Company (2018-2023)
3.2.2 Global Animal-Free Recombinant Proteins Revenue Market Share by Company (2018-2023)
3.3 Global Animal-Free Recombinant Proteins Sale Price by Company
3.4 Key Manufacturers Animal-Free Recombinant Proteins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal-Free Recombinant Proteins Product Location Distribution
3.4.2 Players Animal-Free Recombinant Proteins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Animal-Free Recombinant Proteins by Geographic Region
4.1 World Historic Animal-Free Recombinant Proteins Market Size by Geographic Region (2018-2023)
4.1.1 Global Animal-Free Recombinant Proteins Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Animal-Free Recombinant Proteins Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Animal-Free Recombinant Proteins Market Size by Country/Region (2018-2023)
4.2.1 Global Animal-Free Recombinant Proteins Annual Sales by Country/Region (2018-2023)
4.2.2 Global Animal-Free Recombinant Proteins Annual Revenue by Country/Region (2018-2023)
4.3 Americas Animal-Free Recombinant Proteins Sales Growth
4.4 APAC Animal-Free Recombinant Proteins Sales Growth
4.5 Europe Animal-Free Recombinant Proteins Sales Growth
4.6 Middle East & Africa Animal-Free Recombinant Proteins Sales Growth
5 Americas
5.1 Americas Animal-Free Recombinant Proteins Sales by Country
5.1.1 Americas Animal-Free Recombinant Proteins Sales by Country (2018-2023)
5.1.2 Americas Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
5.2 Americas Animal-Free Recombinant Proteins Sales by Type
5.3 Americas Animal-Free Recombinant Proteins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal-Free Recombinant Proteins Sales by Region
6.1.1 APAC Animal-Free Recombinant Proteins Sales by Region (2018-2023)
6.1.2 APAC Animal-Free Recombinant Proteins Revenue by Region (2018-2023)
6.2 APAC Animal-Free Recombinant Proteins Sales by Type
6.3 APAC Animal-Free Recombinant Proteins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Animal-Free Recombinant Proteins by Country
7.1.1 Europe Animal-Free Recombinant Proteins Sales by Country (2018-2023)
7.1.2 Europe Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
7.2 Europe Animal-Free Recombinant Proteins Sales by Type
7.3 Europe Animal-Free Recombinant Proteins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Animal-Free Recombinant Proteins by Country
8.1.1 Middle East & Africa Animal-Free Recombinant Proteins Sales by Country (2018-2023)
8.1.2 Middle East & Africa Animal-Free Recombinant Proteins Revenue by Country (2018-2023)
8.2 Middle East & Africa Animal-Free Recombinant Proteins Sales by Type
8.3 Middle East & Africa Animal-Free Recombinant Proteins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal-Free Recombinant Proteins
10.3 Manufacturing Process Analysis of Animal-Free Recombinant Proteins
10.4 Industry Chain Structure of Animal-Free Recombinant Proteins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal-Free Recombinant Proteins Distributors
11.3 Animal-Free Recombinant Proteins Customer
12 World Forecast Review for Animal-Free Recombinant Proteins by Geographic Region
12.1 Global Animal-Free Recombinant Proteins Market Size Forecast by Region
12.1.1 Global Animal-Free Recombinant Proteins Forecast by Region (2024-2029)
12.1.2 Global Animal-Free Recombinant Proteins Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Animal-Free Recombinant Proteins Forecast by Type
12.7 Global Animal-Free Recombinant Proteins Forecast by Application
13 Key Players Analysis
13.1 BioVision
13.1.1 BioVision Company Information
13.1.2 BioVision Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.1.3 BioVision Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioVision Main Business Overview
13.1.5 BioVision Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.2.3 Bio-Techne Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Abcam
13.3.1 Abcam Company Information
13.3.2 Abcam Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.3.3 Abcam Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abcam Main Business Overview
13.3.5 Abcam Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Animal-Free Recombinant Proteins Product Portfolios and Specifications
13.4.3 Merck Animal-Free Recombinant Proteins Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Animal-Free Recombinant Proteins Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Animal-Free Recombinant Proteins Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preclinical Proteins
Table 4. Major Players of GMP Proteins
Table 5. Global Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 6. Global Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Table 7. Global Animal-Free Recombinant Proteins Revenue by Type (2018-2023) & ($ million)
Table 8. Global Animal-Free Recombinant Proteins Revenue Market Share by Type (2018-2023)
Table 9. Global Animal-Free Recombinant Proteins Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 11. Global Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Table 12. Global Animal-Free Recombinant Proteins Revenue by Application (2018-2023)
Table 13. Global Animal-Free Recombinant Proteins Revenue Market Share by Application (2018-2023)
Table 14. Global Animal-Free Recombinant Proteins Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Animal-Free Recombinant Proteins Sales by Company (2018-2023) & (K Units)
Table 16. Global Animal-Free Recombinant Proteins Sales Market Share by Company (2018-2023)
Table 17. Global Animal-Free Recombinant Proteins Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Animal-Free Recombinant Proteins Revenue Market Share by Company (2018-2023)
Table 19. Global Animal-Free Recombinant Proteins Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Animal-Free Recombinant Proteins Producing Area Distribution and Sales Area
Table 21. Players Animal-Free Recombinant Proteins Products Offered
Table 22. Animal-Free Recombinant Proteins Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Animal-Free Recombinant Proteins Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Animal-Free Recombinant Proteins Sales Market Share Geographic Region (2018-2023)
Table 27. Global Animal-Free Recombinant Proteins Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Animal-Free Recombinant Proteins Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Animal-Free Recombinant Proteins Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Animal-Free Recombinant Proteins Sales Market Share by Country/Region (2018-2023)
Table 31. Global Animal-Free Recombinant Proteins Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Animal-Free Recombinant Proteins Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 34. Americas Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 35. Americas Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 37. Americas Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 38. Americas Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 39. APAC Animal-Free Recombinant Proteins Sales by Region (2018-2023) & (K Units)
Table 40. APAC Animal-Free Recombinant Proteins Sales Market Share by Region (2018-2023)
Table 41. APAC Animal-Free Recombinant Proteins Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Animal-Free Recombinant Proteins Revenue Market Share by Region (2018-2023)
Table 43. APAC Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 44. APAC Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 45. Europe Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 46. Europe Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 47. Europe Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 49. Europe Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 50. Europe Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Animal-Free Recombinant Proteins Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Animal-Free Recombinant Proteins Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Animal-Free Recombinant Proteins Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Animal-Free Recombinant Proteins Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Animal-Free Recombinant Proteins Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Animal-Free Recombinant Proteins
Table 58. Key Market Challenges & Risks of Animal-Free Recombinant Proteins
Table 59. Key Industry Trends of Animal-Free Recombinant Proteins
Table 60. Animal-Free Recombinant Proteins Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Animal-Free Recombinant Proteins Distributors List
Table 63. Animal-Free Recombinant Proteins Customer List
Table 64. Global Animal-Free Recombinant Proteins Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Animal-Free Recombinant Proteins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Animal-Free Recombinant Proteins Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Animal-Free Recombinant Proteins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Animal-Free Recombinant Proteins Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Animal-Free Recombinant Proteins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Animal-Free Recombinant Proteins Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Animal-Free Recombinant Proteins Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Animal-Free Recombinant Proteins Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Animal-Free Recombinant Proteins Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. BioVision Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 79. BioVision Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 80. BioVision Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. BioVision Main Business
Table 82. BioVision Latest Developments
Table 83. Bio-Techne Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Techne Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 85. Bio-Techne Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bio-Techne Main Business
Table 87. Bio-Techne Latest Developments
Table 88. Abcam Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 89. Abcam Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 90. Abcam Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abcam Main Business
Table 92. Abcam Latest Developments
Table 93. Merck Basic Information, Animal-Free Recombinant Proteins Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Animal-Free Recombinant Proteins Product Portfolios and Specifications
Table 95. Merck Animal-Free Recombinant Proteins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
List of Figures
Figure 1. Picture of Animal-Free Recombinant Proteins
Figure 2. Animal-Free Recombinant Proteins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal-Free Recombinant Proteins Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Animal-Free Recombinant Proteins Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Animal-Free Recombinant Proteins Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preclinical Proteins
Figure 10. Product Picture of GMP Proteins
Figure 11. Global Animal-Free Recombinant Proteins Sales Market Share by Type in 2022
Figure 12. Global Animal-Free Recombinant Proteins Revenue Market Share by Type (2018-2023)
Figure 13. Animal-Free Recombinant Proteins Consumed in Cell Therapy Manufacturing
Figure 14. Global Animal-Free Recombinant Proteins Market: Cell Therapy Manufacturing (2018-2023) & (K Units)
Figure 15. Animal-Free Recombinant Proteins Consumed in Other
Figure 16. Global Animal-Free Recombinant Proteins Market: Other (2018-2023) & (K Units)
Figure 17. Global Animal-Free Recombinant Proteins Sales Market Share by Application (2022)
Figure 18. Global Animal-Free Recombinant Proteins Revenue Market Share by Application in 2022
Figure 19. Animal-Free Recombinant Proteins Sales Market by Company in 2022 (K Units)
Figure 20. Global Animal-Free Recombinant Proteins Sales Market Share by Company in 2022
Figure 21. Animal-Free Recombinant Proteins Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Animal-Free Recombinant Proteins Revenue Market Share by Company in 2022
Figure 23. Global Animal-Free Recombinant Proteins Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Animal-Free Recombinant Proteins Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 26. Americas Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 27. APAC Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 28. APAC Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 29. Europe Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 30. Europe Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Animal-Free Recombinant Proteins Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Animal-Free Recombinant Proteins Revenue 2018-2023 ($ Millions)
Figure 33. Americas Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 34. Americas Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 35. Americas Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 36. Americas Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 37. United States Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Animal-Free Recombinant Proteins Sales Market Share by Region in 2022
Figure 42. APAC Animal-Free Recombinant Proteins Revenue Market Share by Regions in 2022
Figure 43. APAC Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 44. APAC Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 45. China Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 53. Europe Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 54. Europe Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 55. Europe Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 56. Germany Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Animal-Free Recombinant Proteins Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Animal-Free Recombinant Proteins Sales Market Share by Application (2018-2023)
Figure 65. Egypt Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Animal-Free Recombinant Proteins Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Animal-Free Recombinant Proteins in 2022
Figure 71. Manufacturing Process Analysis of Animal-Free Recombinant Proteins
Figure 72. Industry Chain Structure of Animal-Free Recombinant Proteins
Figure 73. Channels of Distribution
Figure 74. Global Animal-Free Recombinant Proteins Sales Market Forecast by Region (2024-2029)
Figure 75. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Animal-Free Recombinant Proteins Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Animal-Free Recombinant Proteins Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Animal-Free Recombinant Proteins Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非動物性組換えタンパク質市場予測 2023年-2029年] (コード:LP23MY4058)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非動物性組換えタンパク質市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆